Table 4.
Field Evaluation of Semen Samples From EBOV Survivors Using Modified Xpert Ebola, MGB, and EZ1 Assays
| Type of Assay | Outcome | Modified Xpert Ebola GP | MGB NP | ||
|---|---|---|---|---|---|
| Outcome | |||||
| Positive | Not Detected | Positive | Not Detected | ||
| Modified Xpert Ebola NP | Positive | 42 | 45 | 10 | 77 |
| Not detected | 3 | 312 | 3a | 312 | |
| EZ1 GP | Positive | 7 | 1a | 6 | 2 |
| Not detected | 38 | 356 | 7 | 387 | |
Abbreviations: EBOV, Ebola virus; EZ1, Ebola Zaire target 1; GP, glycoprotein; MGB, major groove binder; RT-PCR, real-time–polymerase chain reaction; NP, nucleoprotein.
aFour samples were labeled as discordant in that EBOV was detected on the EZ1 GP and/or MGB NP but not detected on the modified Xpert EBOV assay.